Showing results (11-20 of 20) with videos related to
Sort By:
Pageof 2
You have reached the last page of results.This site can display upto 20 results.
Iscience|March 27, 2026
The prognostic utility of a combined PNI-HB immunonutritional index in CD19 CAR T-cell therapy for relapsed/refractory non-Hodgkin lymphomaYifan Liu, Xi Chen, Ping Li, et al.Medicine|December 16, 2014
Retrospective comparison of fludarabine in combination with intermediate-dose cytarabine versus high-dose cytarabine as consolidation therapies for acute myeloid leukemiaWenjun Zhang, Yi Ding, Hao Wu, et al.Frontiers in Immunology|May 21, 2025
Comparison of efficacy and adverse effects of CD19/20 CART versus CD19 single-target CART in R/R DLBCL: a single-center retrospective studyBin Xue, Yifan Liu, Bing Li, et al.Pathology Oncology Research : POR|May 8, 2023
Case report: Circulating tumor DNA technology displays temporal and spatial heterogeneity in Waldenström macroglobulinemia during treatment with <i>BTK</i> inhibitorsJingjing Zhu, Xinyu Zhu, Fengyang Xie, et al.Translational Cancer Research|February 20, 2025
Single nucleotide polymorphism and promoter methylation analysis of protein tyrosine phosphatase 1B in patients with myeloproliferative neoplasmsJie Zhou, Hao Wu, Bing Li, et al.Frontiers in Genetics|June 28, 2021
Whole Transcriptome Data Analysis Reveals Prognostic Signature Genes for Overall Survival Prediction in Diffuse Large B Cell LymphomaMengmeng Pan, Pingping Yang, Fangce Wang, et al.Zhonghua Xue Ye Xue Za Zhi = Zhonghua Xueyexue Zazhi|April 29, 2015
[Treatment of Ph-adult acute lymphoblastic leukemia patients with Tongji-96 regimen]Yi Ding, Ping Li, Wenjun Zhang, et al.Frontiers in Immunology|July 1, 2026
Predicting CAR-T outcomes in R/R DLBCL: a multicenter real-world study of a 5-index modelBin Xue, Huina Lu, Yifan Liu, et al.Experimental and Therapeutic Medicine|February 14, 2018
Efficacy and safety of combined immunosuppressive therapy plus umbilical cord blood infusion in severe aplastic anemia patients: A cohort studyXiu Luo, Huina Lu, Bing Xiu, et al.Cell Reports. Medicine|November 11, 2023
A combinatorial therapeutic approach to enhance FLT3-ITD AML treatmentJun Long, Xinjie Chen, Yan Shen, et al.Pageof 2